AbbVie Inc.

04/23/2021 | Press release | Distributed by Public on 04/23/2021 06:09

AbbVie Receives Positive CHMP Opinion for VENCLYXTO® (venetoclax) as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for[...]